Related Experiment Video
Updated: Jan 14, 2026
Lipidomics and Transcriptomics in Neurological Diseases
Published on: March 18, 2022
Cuminaldehyde improves seizures by reducing the expression of TNF-α, iNOS, nNOS, and oxidative stress in the
Najmeh Asgharzadeh1, Parsa Eshragh1, Hossein Amini-Khoei1
1Medical Plants Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Introduction And Objective:
Neuroinflammation is a significant contributor to seizure occurrence. This study examines the anticonvulsant effects of cuminaldehyde.
Materials And Methods:
Forty-eight NMRI mice weighing 25-30 grams and 2 months old were obtained from the Pasteur Institute of Tehran and divided into six groups: Control group (Normal saline 10 ml/kg), Saline group (Normal saline 10 ml/kg + pentylenetetrazol 90 mg/kg), Cuminaldehyde 12.5 group (Cuminaldehyde 12.5 mg/kg + pentylenetetrazol 90 mg/kg), Cuminaldehyde 25 group (Cuminaldehyde 25 mg/kg + pentylenetetrazol 90 mg/kg), Cuminaldehyde 50 group (Cuminaldehyde 50 mg/kg + pentylenetetrazol 90 mg/kg), Diazepam group (Diazepam 3 mg/kg + pentylenetetrazol 90 mg/kg). Treatments were administered for seven consecutive days. On the eighth day, seizures were induced in all groups except the control group. One hour after the final dose of cuminaldehyde, pentylenetetrazol (90 mg/kg) was administered via intravenous injection. The latency to seizure onset was recorded.On the ninth day, the mice were anesthetized using ketamine (100 mg/kg) and xylazine (10 mg/kg). Blood samples were collected, and the brains were removed. The serum and hippocampus were separated and stored at -80 °C until further analysis. Nitrite levels, total antioxidant capacity, and malondialdehyde levels in serum and hippocampus were measured. The expression levels of TNF-α, iNOS, and nNOS genes in the hippocampus were analyzed using real-time RT-PCR.
Results:
Seizure induction in the saline group significantly increased nitrite and malondialdehyde levels and decreased hippocampal antioxidant capacity (p < 0.001). Cuminaldehyde and diazepam prolonged seizure onset latency (p < 0.001), with diazepam showing greater efficacy than the 12.5 mg/kg and 25 mg/kg cuminaldehyde groups. Cuminaldehyde improved hippocampal antioxidant capacity, lowered nitrite and malondialdehyde levels (p < 0.001), and reduced TNF-α, iNOS, and nNOS gene expression compared to the saline group (p < 0.001).
Conclusion:
Cuminaldehyde delays seizure onset by enhancing antioxidant defenses, mitigating oxidative stress, and downregulating TNF-α, iNOS, and nNOS gene expression in the hippocampus, demonstrating potential as an anticonvulsant.
Insights
Cuminaldehyde demonstrates anticonvulsant properties by improving antioxidant defenses and reducing neuroinflammation markers. This natural compound shows promise in delaying seizure onset and mitigating oxidative stress in the hippocampus.
Area of Science:
- Neuroscience
- Pharmacology
- Biochemistry
Background:
- Neuroinflammation is a key factor in seizure development.
- Oxidative stress and elevated pro-inflammatory markers contribute to seizure susceptibility.
- Natural compounds are being investigated for their therapeutic potential in neurological disorders.
Purpose of the Study:
- To evaluate the anticonvulsant effects of cuminaldehyde.
- To investigate the impact of cuminaldehyde on oxidative stress markers and neuroinflammation in a mouse model of seizures.
Main Methods:
- NMRI mice were treated with cuminaldehyde or diazepam before pentylenetetrazol-induced seizures.
- Seizure latency was recorded, and biochemical analyses of serum and hippocampus were performed.
- Measurements included nitrite, malondialdehyde, total antioxidant capacity, and gene expression of TNF-α, iNOS, and nNOS.
Main Results:
- Cuminaldehyde significantly prolonged seizure onset latency.
- Treatment with cuminaldehyde reduced oxidative stress by decreasing nitrite and malondialdehyde levels and increasing antioxidant capacity.
- Cuminaldehyde downregulated the expression of TNF-α, iNOS, and nNOS genes in the hippocampus.
Conclusions:
- Cuminaldehyde exhibits significant anticonvulsant activity.
- The mechanism involves enhancing antioxidant defenses and reducing neuroinflammation.
- Cuminaldehyde shows potential as a therapeutic agent for seizure disorders.
More Related Videos
08:47Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats
Published on: November 8, 2018
09:07Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017
Related Concept Videos
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
01:14Antiepileptic Drugs: Glutamate Antagonists
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
01:24Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...